Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,056 | 37,219 | 42,131 | 51,108 | 54,839 |
| Receivables | 956 | 716 | N/A | N/A | N/A |
| TOTAL | $37,236 | $40,178 | $44,896 | $51,596 | $55,399 |
| Non-Current Assets | |||||
| PPE Net | 338 | 342 | 378 | 363 | 407 |
| Intangibles | 0 | 0 | 0 | 0 | 19,092 |
| Other Non-Current Assets | 267 | 320 | 373 | 424 | 474 |
| TOTAL | $605 | $662 | $751 | $787 | $19,973 |
| Total Assets | $37,841 | $40,840 | $45,647 | $52,383 | $75,372 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,937 | 976 | 1,378 | 2,571 | 1,314 |
| Other current liabilities | N/A | N/A | 0 | N/A | 1 |
| TOTAL | $3,145 | $1,216 | $1,619 | $2,813 | $1,558 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 27 | 57 | 119 | 177 | 234 |
| TOTAL | $27 | $57 | $119 | $177 | $234 |
| Total Liabilities | $3,172 | $1,273 | $1,738 | $2,990 | $1,792 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,174 | 8,143 | 8,143 | 8,119 | 8,119 |
| Common Shares | 8 | 8 | 8 | 98 | 98 |
| Retained earnings | -303,119 | -297,930 | -293,429 | -287,729 | -263,301 |
| TOTAL | $34,669 | $39,567 | $43,909 | $49,393 | $73,580 |
| Total Liabilities And Equity | $37,841 | $40,840 | $45,647 | $52,383 | $75,372 |